Frequently Asked Questions

Yes, combining peptides with complementary mechanisms is common and generally safe when each peptide is understood individually first. Popular research combinations include BPC-157 + TB-500 (recovery synergy), CJC-1295 + Ipamorelin (GH optimisation), Semaglutide + Ipamorelin (metabolic support + lean mass preservation), and Semax + Selank (cognitive + anxiolytic). Start with individual peptides before adding combinations, and give each protocol 4–8 weeks to assess response.

PT-141 (Bremelanotide) is a melanocortin receptor agonist that works centrally — it targets the brain's arousal pathways rather than blood flow. Traditional ED treatments like sildenafil (Viagra) work peripherally by relaxing smooth muscle and increasing penile blood flow but require sexual stimulation to work. PT-141 can initiate sexual desire directly. It is also the only peptide studied for hypoactive sexual desire disorder (HSDD) in women.

BPC-157 (Body Protection Compound 157) was originally isolated from human gastric juice. It promotes healing of the stomach lining, intestinal wall, and colorectal tissue by upregulating growth factor expression (EGF, VEGF), accelerating re-epithelialisation, and modulating nitric oxide pathways. It is one of the few peptides studied specifically for IBD, leaky gut, NSAID damage, and anastomosis healing in animal models.

BPC-157 is consistently the top choice for tendon and ligament injuries. It has demonstrated accelerated healing in numerous rat studies involving Achilles tendon transection, rotator cuff damage, and ACL injury. TB-500 (Thymosin Beta-4) is the preferred complement — it reduces inflammation systemically and promotes actin cell migration essential for tissue repair. Stacking both is the most studied protocol for soft tissue recovery.

Epithalon (Epitalon) is a synthetic tetrapeptide that activates telomerase — the enzyme that extends telomeres. It was developed by the St. Petersburg Institute of Bioregulation and Gerontology under Dr. Vladimir Khavinson. Russian studies show normalisation of circadian rhythms, improved antioxidant capacity, and reduced age-related DNA damage in both animal and human trials. Long-term human safety data is limited.

Semax primarily acts by upregulating BDNF (brain-derived neurotrophic factor) and modulating dopaminergic and serotonergic systems — it is more of a cognitive activator and focus enhancer. Selank primarily modulates the GABAergic system and enkephalin metabolism — it is more of an anxiolytic and stress reducer. They are often stacked for combined effect: Semax for drive and clarity, Selank for calm and mood stability.

Semax and Selank are the most researched nootropic peptides. Semax is a synthetic analogue of ACTH that increases BDNF, improves focus, memory, and stress resilience. Selank is a tuftsin analogue with anxiolytic and nootropic effects comparable to benzodiazepines but without sedation or dependence. Dihexa (PNT2258) and Epithalon are also studied for cognitive and longevity effects respectively.

5-Amino-1MQ is a small molecule that inhibits NNMT (nicotinamide N-methyltransferase), an enzyme that consumes SAM-e and lowers NAD+ in fat cells. By blocking NNMT, 5-Amino-1MQ allows NAD+ to rise naturally within adipocytes, promoting fat cell shrinkage and metabolic function. NMN and NR work by providing precursors to raise NAD+ systemically. 5-Amino-1MQ targets fat-cell NAD+ specifically through a different mechanism.

AOD-9604 (Advanced Obesity Drug) is a synthetic fragment of human growth hormone (amino acids 176–191). It mimics the fat-burning portion of HGH without the anabolic or blood sugar effects of full HGH. It stimulates lipolysis (fat breakdown) and inhibits lipogenesis (fat storage), particularly in adipose tissue. It does not affect IGF-1 levels.

Semaglutide is a GLP-1 receptor agonist. Tirzepatide is a dual GLP-1 and GIP agonist — the addition of GIP action produces greater weight loss than semaglutide alone (average –22% body weight in trials). Retatrutide is a triple agonist adding glucagon receptor activity on top of GLP-1 and GIP, showing the highest weight loss in early trials (–24% at 48 weeks). More agonist targets generally means more potent metabolic effect but also more complex side effect profiles.

GLP-1 (glucagon-like peptide-1) receptor agonists are a class of peptides that mimic the gut hormone GLP-1, which is released after eating. They slow gastric emptying, reduce appetite, improve insulin sensitivity, and promote fat loss. Semaglutide (Ozempic/Wegovy) and tirzepatide (Mounjaro) are FDA-approved GLP-1 agonists. Retatrutide is a triple agonist (GLP-1 + GIP + glucagon) in late-stage trials.

MK-677 (Ibutamoren) is an oral ghrelin mimetic — a non-peptide compound that activates the same ghrelin receptor as injectable GHRPs. It is taken orally and has a 24-hour half-life, producing sustained GH and IGF-1 elevation throughout the day. The trade-off is that it also increases appetite significantly and may raise fasting blood glucose. It is popular for those who prefer oral dosing.

Ipamorelin is selective for the ghrelin receptor in the pituitary and produces a clean GH pulse without meaningfully increasing cortisol, prolactin, or ACTH — side effects associated with other GHRPs like GHRP-2 and GHRP-6. This selectivity makes it the preferred starting point for GH secretagogue research. It also does not significantly stimulate appetite, unlike GHRP-6.

Both are GHRH analogues that stimulate growth hormone release, but CJC-1295 DAC has a much longer half-life (6–8 days) due to a Drug Affinity Complex modification. Sermorelin has a half-life of only 10–20 minutes and produces a more natural, pulsatile GH release. CJC-1295 without DAC (also called Mod GRF 1-29) has a shorter half-life similar to Sermorelin and is preferred for pulsatile dosing.

Growth hormone secretagogues are peptides that stimulate the pituitary gland to produce and release more of your own growth hormone. They do not introduce synthetic growth hormone into your body — they amplify your natural GH pulses. The main types are GHRH analogues (CJC-1295, Sermorelin) that extend the GH release window, and GHRP/ghrelin mimetics (Ipamorelin, MK-677) that stimulate GH pulse amplitude.

A cloudy or particulate solution can indicate degradation, bacterial contamination, or improper reconstitution. Do not inject a cloudy solution. If the peptide was stored correctly and reconstituted properly, a small amount of cloudiness sometimes resolves by gently swirling and letting the vial sit at room temperature for a few minutes. Persistent cloudiness means the vial should be discarded.

Avoid it. Reconstituted peptides should be kept refrigerated, not frozen. Freezing a reconstituted solution risks degrading the peptide structure through ice crystal formation. If you need longer storage, keep the peptide as lyophilised powder in the freezer and only reconstitute what you will use within the month.

Once reconstituted with bacteriostatic water, most peptides remain stable for 4–6 weeks refrigerated at 2–8°C. Some peptides such as GHK-Cu are more fragile and should be used within 2–3 weeks. Always label vials with the reconstitution date and discard anything older than 6 weeks, or sooner if the solution appears cloudy, discoloured, or has visible particles.

Lyophilised peptide powder is best stored in a freezer at –20°C for long-term stability (12+ months). Short-term storage at room temperature (a few weeks) is acceptable for most peptides if kept away from heat and light. Never expose peptide vials to direct sunlight or temperatures above 30°C.

Timing depends on the peptide. Growth hormone secretagogues (Ipamorelin, CJC-1295, Sermorelin) are most effective injected 30–60 minutes before sleep — natural GH pulses occur during deep sleep. BPC-157 and TB-500 can be injected any time. GLP-1 agonists like semaglutide are typically once-weekly regardless of time. Always refer to the specific protocol for the peptide you are using.

Most research peptides are injected subcutaneously (under the skin, not into muscle). Common injection sites are the lower abdomen (2–3cm from the navel), the outer thigh, and the deltoid. Rotate sites to avoid tissue build-up. Pinch the skin lightly, insert the needle at a 45–90° angle, and inject slowly.

32-gauge, 6mm (1/4 inch) insulin syringes are the standard. The 32G ultra-fine tip minimises discomfort and the 6mm length reliably reaches the subcutaneous layer without going too deep. Longer or thicker needles are unnecessary and increase pain. Always use a fresh sterile needle for every injection.

It depends on the dose you want per tick on an insulin syringe. A common convention: add 1mL of BAC water to a 5mg vial, giving you 50mcg per 1 IU (tick) on a U-100 syringe. For 10mg vials, use 2mL for the same result. You can adjust the volume to make your target dose convenient to draw. A dosage calculator makes this easy.

Bacteriostatic water is sterile water containing 0.9% benzyl alcohol, which prevents bacterial growth. It is the only correct solvent for reconstituting injectable peptides because it preserves the solution for 4–6 weeks. Regular water, distilled water, or saline are not acceptable substitutes — they contain no preservative and will allow bacterial contamination within hours.

Use a sterile 3mL drawing syringe to draw the required volume of bacteriostatic water (BAC water). Wipe the top of the peptide vial with an alcohol swab. Insert the needle and inject the BAC water slowly down the inside wall of the vial — do not aim directly at the powder. Swirl gently (never shake) until fully dissolved. Label the vial with the date.

Lyophilisation (freeze-drying) is the process used to preserve peptides in powder form for storage and shipping. The peptide is dissolved in water, frozen, and then dehydrated under vacuum. The resulting powder is stable at room temperature for months — far longer than a liquid solution. All research peptides arrive as lyophilised powder and must be reconstituted before use.

Legal status varies by country and by the specific peptide. In the US, most research peptides are sold legally as research chemicals — meaning they are not approved by the FDA for human consumption. Peptides like semaglutide (Ozempic) are FDA-approved medications that require a prescription. Always verify the legal status of any compound in your jurisdiction before purchasing or using it.

It is purely a matter of size. Peptides are chains of fewer than 50 amino acids; proteins are chains of 50 or more. In practice, the line is blurry — insulin, for example, is 51 amino acids and is technically a protein but is often classified as a peptide. Research peptides are generally small enough to be synthesised in a lab and precise enough to target specific receptors.

No. Peptides, steroids, and hormones are fundamentally different classes of compounds. Steroids (like testosterone) directly replace or add hormones to your system and suppress natural production. Peptides are signaling molecules — they prompt your body to produce more of something (like growth hormone) rather than delivering the hormone directly. The risk profiles are also very different.

Peptides are short chains of 2–50 amino acids — the same building blocks that make up proteins. They occur naturally in every cell of the human body and act as signaling molecules, telling tissues to repair, hormones to release, and immune cells to respond. Synthetic research peptides are designed to replicate or amplify these natural signals with high specificity.

Research peptides are sold for in vitro (outside a living organism) and in vivo (in animal models) scientific research purposes only — not for human consumption or therapeutic use. This designation reflects both regulatory requirements and the stage of clinical evidence for most compounds documented here.

The legal status of research peptides varies significantly by country, jurisdiction, and intended use. In many regions they are sold legally as research chemicals not for human consumption. It is your responsibility to understand and comply with the laws in your jurisdiction. Peptide Oracle does not sell any products.

Bacteriostatic water (BAC water) is sterile water containing 0.9% benzyl alcohol, which inhibits bacterial growth. It is the standard solvent for reconstituting lyophilized (freeze-dried) research peptides because it extends the stability of the reconstituted solution compared to plain sterile water.

Enter your vial amount (in mg), the volume of BAC water you added (in mL), and your desired dose (in mcg). The calculator outputs exactly how many units to draw on a standard 100-unit insulin syringe and how many doses you can expect per vial.

No account is required to read the Peptide Library, Research Desk, Stacking Guides, or use the Dosage Calculator. Creating a free account lets you bookmark content and track your reading history.

No. Peptide Oracle is a pure education and research reference. Nothing on this site constitutes medical advice, a treatment recommendation, or a protocol suggestion. Consult a qualified healthcare professional before making any health-related decisions.

Peptides are short chains of amino acids — the same building blocks that make up proteins, just in smaller sequences. They are naturally occurring in the body and act as signaling molecules that influence everything from hormone release to tissue repair. The peptides documented here are synthetic versions studied in research settings.